Cell-permeable transgelin-2 as a potent therapeutic for dendritic cell-based cancer immunotherapy

Hye-Ran Kim(University of Rochester Medical Center), Chang‐Duk Jun(Gwangju Institute of Science and Technology)
Journal of Hematology & Oncology
March 17, 2021
Cited by 18


Related Papers